- Home
- NERV vs INBK Comparison
NERV vs INBK Comparison
Compare NERV & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NERV | INBK |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.7M | 181.7M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | NERV | INBK |
|---|---|---|
| Price | $6.31 | $20.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $4.00 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 98.5K | 47.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | ★ 104.12 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,175,600.00 | N/A |
| Revenue This Year | N/A | $279.34 |
| Revenue Next Year | N/A | $12.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.15 | $17.05 |
| 52 Week High | $12.46 | $31.04 |
Technical Indicators
Market Signals| Indicator | NERV | INBK |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 40.35 |
| Support Level | $5.66 | $20.37 |
| Resistance Level | $6.69 | $21.76 |
| Average True Range (ATR) | 0.57 | 0.98 |
| MACD | 0.11 | -0.22 |
| Stochastic Oscillator | 84.44 | 3.54 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.